Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2911-2917

  Gritters, Mareille ^a,b   Borgdorff, Piet ^b   Grooteman, Muriel P C ^b   Schoorl, Marianne ^a   Schoorl, Margreet ^a   Bartels, Piet C M ^a   Tangelder, Geert Jan ^b   Nubé, Menso J ^a,b  

^a Location Alkmaar   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anticoagulation; Bio incompatibility; Haemodialysis; Platelet activation; Platelet factor 4

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; SEROTONIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SEROTONIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET FACTOR 4; RENAL DIALYSIS; RENAL INSUFFICIENCY; SEROTONIN;

EID: 58549109620     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn137     Document Type: Article

References (21)

1. Cianciolo G, Stefoni S, Donati G et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs. polysulfone membranes. Nephrol Dial Transplant 2001; 16: 1222-1229
2. Pitsilos S, Hunt J, Mohler ER et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 2003; 90: 1112-1120
3. Yu G, Rux AH, Ma P et al. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 2005; 105: 3545-3551
4. Nassar T, Sachais BS, Akkawi S et al. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003; 278: 6187-6193
5. Davi G, Patrono C. Platelet activation and atherothrombosis. NEJM 2007; 357: 2482-2494
6. Borgdorff P, Fekkes D, Tangelder GJ. Hypotension caused by extra-corporeal circulation: serotonin from pump-activated platelets triggers nitric oxide release. Circulation 2002; 106: 2588-2593
7. Aggarwal A, Whitaker DA, Rimmer JM et al. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis. Nephrol Dial Transplant 2004; 19: 1559-1563
8. Stefoni S, Cianciolo G, Donati G et al. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in haemodialysis. Nephron 2002; 92: 589-600
9. Gritters M, Grooteman MP, Schoorl M et al. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006; 21: 153-159
10. Bos JC, Grooteman MP, Van Houte AJ et al. Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997; 12: 1387-1393
11. Böhler J, Schollmeyer P, Dressel B et al. Reduction of granulocyte activation during haemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7: 234-241
12. Myrup B, Yokoyama H, Kristiansen OP et al. Release of endothelium-associated proteins into blood by injection of heparin in normal subjects and in patients with type 1 diabetes. Diabet Med 2004; 21: 1135-1140
13. Dawes J, Pumphrey CW, McLaren KM et al. The in vivo release of human platelet factor 4 by heparin. Thromb Res 1982; 27: 65-76
14. Westwick J, Scully MF, Poll C et al. Comparison of the effects of LMWH and unfractionated heparin on activation of human. Thromb Res 1986; 42: 435-447
15. Rucinski B, Knight LC, Niewiarowski S. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin. Am J Physiol 1986; 251: H800-H807
16. Zoltowski R, Pawlak R, Matys T et al. Propanolol modifies platelet serotonergic mechanisms in rats. J Physiol Pharmacol 2002; 53: 265-274
17. Fardaee M, Panjehshahin MR, Owji AA et al. Serotonin levels in plasma and platelets of cyclosporine A treated rats. Irn J Med Sci 1998; 23: 89-93
18. Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Am J Kidney Dis 1996; 27: 355-364
19. Heinzelmann M, Mercer-Jones MA, Passmore JC. Neutrophils and renal failure. Am J Kidney Dis 1999; 34: 384-399
20. Schoorl M, Schoorl M, Bartels PC. Changes in platelet volume, morphology and RNA content in subjects treated with haemodialysis. Scan J Clin Lab Invest, in press, e-pub 18-12-2007 (www. informaworld.com)
21. Golański J, Pietrucha T, Baj Z et al. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 1996; 83: 199-216